Evidence map›Paper›PMID 28690686›Full record

ReviewJournal of neurodevelopmental disorders2017

Vagus nerve stimulation as a potential adjuvant to behavioral therapy for autism and other neurodevelopmental disorders.

Crystal T Engineer, Seth A Hays, Michael P Kilgard

Open access · goldAbstract readReview
In one paragraph

Review in Journal of neurodevelopmental disorders, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Neuromodulation and the Gut-Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders.Pathophysiology : the official journal of the International Society for Pathophysiology · 2024
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Crystal T EngineerTexas Biomedical Device Center, The University of Texas at Dallas, 800 West Campbell Road BSB11, Richardson, TX 75080 USA.
Seth A HaysTexas Biomedical Device Center, The University of Texas at Dallas, 800 West Campbell Road BSB11, Richardson, TX 75080 USA.
Michael P KilgardTexas Biomedical Device Center, The University of Texas at Dallas, 800 West Campbell Road BSB11, Richardson, TX 75080 USA.
The University of Texas at Dallas · US

Funding

Targeted Neural Plasticity for the Treatment of TinnitusR44DC010084 · NIDCD · MICROTRANSPONDER, INC. · PI ENGINEER, NAVZER, KILGARD, MICHAEL P · 2010 to 2011
$2.1M
Vagus Nerve Stimulation Paired with Rehabilitative Training to Enhance PlasticityR01NS085167 · NINDS · UNIVERSITY OF TEXAS DALLAS · PI KILGARD, MICHAEL P, RENNAKER, ROBERT L · 2014 to 2018
$1.9M
Evaluation of the Neuromodulatory Mechanisms of Vagus Nerve Stimulation to Improve Motor Rehabilitation after StrokeR01NS094384 · NINDS · UNIVERSITY OF TEXAS DALLAS · PI HAYS, SETH ALANSON · 2016 to 2020
$1.7M
Animal Model of Speech Sound Processing in AutismR01DC010433 · NIDCD · UNIVERSITY OF TEXAS DALLAS · PI KILGARD, MICHAEL P · 2010 to 2014
$1.4M
NIDCD NIH HHS R01 DC010433NIDCD NIH HHS R44 DC010084NINDS NIH HHS R01 NS085167NINDS NIH HHS R01 NS094384
6 · The paper itself

Abstract

backgroundMany children with autism and other neurodevelopmental disorders undergo expensive, time-consuming behavioral interventions that often yield only modest improvements. The development of adjunctive interventions that can increase the benefit of rehabilitation therapies is essential in order to improve the lives of individuals with neurodevelopmental disorders. MAIN TEXT: Vagus nerve stimulation (VNS) is an FDA approved therapy that is safe and effective in reducing seizure frequency and duration in individuals with epilepsy. Individuals with neurodevelopmental disorders often exhibit decreased vagal tone, and studies indicate that VNS can be used to overcome an insufficient vagal response. Multiple studies have also documented significant improvements in quality of life after VNS therapy in individuals with neurodevelopmental disorders. Moreover, recent findings indicate that VNS significantly enhances the benefits of rehabilitative training in animal models and patients, leading to greater recovery in a variety of neurological diseases. Here, we review these findings and provide a discussion of how VNS paired with rehabilitation may yield benefits in the context of neurodevelopmental disorders.

conclusionsVNS paired with behavioral therapy may represent a potential new approach to enhance rehabilitation that could significantly improve the outcomes of individuals with neurodevelopmental disorders.

Indexed as

AutismCortexCortical reorganizationPlasticityVagal nerve

Identifiers

PMID28690686
PMCPMC5496407
OpenAlexW2615007391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.